IDEAYA Biosciences, Inc. (IDYA)
40.11
-1.66
(-3.97%)
USD |
NASDAQ |
Aug 28, 16:00
40.11
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Debt to Equity Ratio : 0.0244 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0244 |
| March 31, 2026 | 0.0305 |
| December 31, 2025 | 0.0273 |
| September 30, 2025 | 0.0249 |
| June 30, 2025 | 0.0277 |
| March 31, 2025 | 0.0254 |
| December 31, 2024 | 0.0181 |
| September 30, 2024 | 0.0159 |
| June 30, 2024 | 0.002 |
| March 31, 2024 | 0.0026 |
| December 31, 2023 | 0.0046 |
| September 30, 2023 | 0.0041 |
| June 30, 2023 | 0.0051 |
| March 31, 2023 | 0.0091 |
| December 31, 2022 | 0.01 |
| September 30, 2022 | 0.0106 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0162 |
| March 31, 2022 | 0.0165 |
| December 31, 2021 | 0.0172 |
| September 30, 2021 | 0.0176 |
| June 30, 2021 | 0.0249 |
| March 31, 2021 | 0.0272 |
| December 31, 2020 | 0.0339 |
| September 30, 2020 | 0.0363 |
| June 30, 2020 | 0.0361 |
| March 31, 2020 | 0.0729 |
| December 31, 2019 | 0.0675 |
| September 30, 2019 | 0.0638 |
| June 30, 2019 | 0.0617 |
| March 31, 2019 | 0.0964 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp. | 0.006 |
| Xencor, Inc. | 0.338 |
| UroGen Pharma Ltd. | -1.481 |
| MeiraGTx Holdings Plc | 0.521 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.310B |
| Total Liabilities (Quarterly) | 110.79M |
| Shareholders Equity (Quarterly) | 1.199B |
| Current Ratio | 10.45 |
| Net Debt Paydown Yield | -0.02% |